Babban Sakamako
A gwajin da aka gudanar kan mutane 54 masu cutar rheumatoid arthritis (RA), an ba su 100 mg na coenzyme Q10 (CoQ10) a kowace rana. Bayan makonni takwas, matsakaicin ƙimar DAS‑28 ya tashi daga 5.01 zuwa 2.34, wato kusan 53 % ƙasa. Wannan canjin yana wuce gona da iri a tsarin DAS‑28 inda ƙima sama da 3.2 ke nuna ciwon na aiki, kuma ƙasa da 2.6 ake ɗauka a matsayin remission.
Abin da ya ba mu mamaki shi ne ƙungiyar da ta karɓi placebo ma ta samu raguwar alamar. A ƙasa muna taƙaita abin da gwajin ya nuna da abin da ba ya nuna.
Nazari a Taƙaice
Takardar da aka wallafa a Clinical Rheumatology (2019) ta fito daga masu bincike a Iran – jami’o’in Kermanshah, Tabriz da Urmia.
- Tsari: gwaji na ƙari-randomized, double‑blind, placebo‑controlled
- Masu halarta: manya 54 da ke da RA, shekaru 18‑56, an gane cutar aƙalla watanni 6 da suka wuce, suna da ciwon na aiki (DAS‑28 > 3.2)
- Rukuni: 27 sun sha 100 mg CoQ10 a rana, 27 suka karɓi placebo
- Tsawon lokaci: makonni 8 (watanni 2)
- Yanayi: duk mahalarta sun ci gaba da shan maganin RA na yau da kullum, don haka CoQ10 ƙari ne, ba maye gurbin magani ba
- Abubuwan da aka auna: serum MMP‑1 da MMP‑3, DAS‑28, darajar ciwo, adadin gabobin da ke da zafi da waɗanda suka kumbura
Sakamako a Jadawali
| Ma'auni | CoQ10 | Placebo |
|---|---|---|
| DAS‑28 (matsakaici) | 5.01 → 2.34 | 4.88 → 4.04 |
| Adadin gabobin da suka kumbura (median) | 2 → 0 | 2 → 0 |
| MMP‑1 (median) | 0.20 → 0.16 | 0.18 → 0.15 |
| MMP‑3 (median) | babu ƙaruwa mai ma’ana | 2.26 → 2.57 (P = 0.020) |
Bayan makonni takwas, ƙungiyoyin sun bambanta sosai a DAS‑28 (P < 0.001), darajar ciwo (P < 0.001), adadin gabobin da ke da zafi (P < 0.001) da kuma adadin gabobin da suka kumbura (P = 0.012). A rukuni na CoQ10, ESR (alamar kumburi), darajar ciwo da adadin gabobin da ke da zafi kuma sun inganta sosai (P = 0.001, P < 0.001 da P < 0.001). Takardar ba ta nuna irin waɗannan canje‑canje a rukuni na placebo ba.
Placebo Ma Ya Inganta
Rukuni na placebo ya samu raguwar DAS‑28 daga 4.88 zuwa 4.04 – raguwar da ke da ma’ana (P = 0.009). Haka zalika adadin gabobin da suka kumbura da MMP‑1 suma sun ragu a rukuni biyu. Irin wannan al’amari yana yawan faruwa a gwaje‑gwajen RA; cutar kan canzawa‑cajiye, an sa idanu sosai kan mahalarta, kuma tsammanin su kan iya shafar sakamakon. Don haka, duba “kafin da bayan” na CoQ10 kadai ba ya isa; dole ne a duba gibin da ke tsakanin rukuni biyu. Wannan gibs yana da ma’ana a ƙididdiga, amma furucin “rabi ya ƙare” yana nuni ne kawai ga rukuni na CoQ10.
Menene MMP‑3, Kuma Me Ya Sa Yake Da Muhimmanci?
Matrix metalloproteinases (MMPs) su ne enzymes da ke rushe ƙwayoyin haɗin gwiwa. A RA, ƙwayoyin gwiwa masu kumburi suna fitar da su da yawa. MMP‑3 (stromelysin‑1) yana rushe sinadaran cartilage kuma yana kunna wasu MMPs, don haka ana amfani da shi a matsayin alamar lalacewar gwiwa. Mafi girman matakin MMP‑3 na nuni da ciwo mai tsanani da kuma lalacewa.
A wannan gwajin, MMP‑3 ya ƙaru sosai a rukunin placebo (2.26 → 2.57) amma ba a rukunin CoQ10 ba. Bambanci tsakanin rukuni biyu ya kasance mai ma’ana (P = 0.027). Masu binciken sun fassara hakan a matsayin CoQ10 “yana hana” ƙaruwa da aka gani a placebo, ba cewa yana rage matakin daga tushe ba.
MMP‑1, wani collagenase, ya ragu a duk rukuni biyu, don haka ba ya bambanta CoQ10 daga placebo.
Me Ya Sa CoQ10 Zai Iya Taimakawa?
CoQ10 wani sinadari ne da ke narkewa a cikin mai, yana zaune a membrane na mitochondria inda yake ɗaukar lantarki don samar da ƙarfi. Haka kuma yana aiki a matsayin antioxidant. Ciwon kumburi mai tsawo yana da alaka da oxidative stress da rashin lafiyar mitochondria, kuma an nuna cewa CoQ10 na iya rage waƙaƙƙen kumburi, ciki har da hanyoyin da ke haifar da fitar MMPs. Gwajin bai tantance waɗannan hanyoyi kai tsaye ba, don haka yanzu su ne ra’ayoyi masu yiwuwa, ba shaidu tabbatattu ba.
Iyakoki Da Ya Kamata A Sani
- Karami kuma gwaji ɗaya: mutane 54, makonni 8, aikin bincike guda ɗaya. Ana buƙatar maimaitawa a ƙarin jama'a.
- Tsawon lokaci ƙanƙanta: ba a da bayanai kan lalacewar gwiwa na dogon lokaci, ci gaban X‑ray ko remission.
- Kari ne kawai: mahalarta sun ci gaba da shan maganin RA da suka saba. Ba abin da ke nuna CoQ10 zai maye gurbin DMARDs ko biologics.
- Alamomin gwaji: MMP‑3 alama ce, ba shaidar kariyar gwiwa ba.
- Ƙungiya kaɗan: manya masu shekaru 18‑56 da ke da matakin ciwon matsakaici ko fiye.
Masu rubutun suna kammala da tunani cewa CoQ10 “na iya zama sabon ƙari mai amfani”.
Abin Da Ya Shafi Ku
Matsakaicin da aka gwada: 100 mg a rana tsawon makonni 8. Takaitaccen ba ya fayyace wane irin samfur ko lokacin shan sa.
Lokacin shan: CoQ10 yana narkewa a mai, don haka yawanci ana ba da shawarar a sha tare da abinci mai mai. Wannan ƙa’ida ce gabaɗaya, ba wai gwajin ya gwada ba.
Ubiquinone vs. ubiquinol: ubiquinone shine yanayin da ya oxidize, mafi arha kuma aka fi amfani da shi. Ubiquinol shi ne yanayin da aka rage, yana da tsada. Takaitaccen ba ya bayyana wanne aka yi amfani da shi, don haka ba shi da hujja a gwaji don biyan kuɗi mafi tsada na ubiquinol. Duk wanne kake zaɓa, ka zaɓi alamar da aka gwada a ƙwararrun cibiyoyi.
Masu shan statin: statins suna rage samar da CoQ10 a jiki; don haka haɗin gwiwa na iya tasowa. Ka tambayi likitan ka kafin ƙara shi.
Wanda zai iya dacewa: manya da ke da RA mai aiki, waɗanda suka riga sun karɓi magani, kuma suna son ƙari. Ya kamata su tattauna da rheumatologist kafin farawa.
- Kowa da ke shirin daina ko rage maganin RA saboda CoQ10: Kada su yi hakan.
- Masu shan warfarin: CoQ10 na iya rage tasirin warfarin, don haka a duba INR kullum.
- Masu shan maganin hawan jini, na sikari, ko mata masu ciki da masu shayarwa: Su nemi shawara daga ƙwararren likita.
- Duk wanda ya kasance ƙasa da shekara 18 ko sama da 56: Gwajin bai haɗa su ba.
Gabaɗaya
Wani ƙarin farashi ƙanana, wanda ake samu a sauƙaƙe, ya nuna ingantacciyar raguwar alamomin cutar RA da kuma yanayin MMP‑3 mafi kyau idan aka kwatanta da placebo. Wannan abu ne mai ban sha'awa, amma shaidar ta fito ne daga gwaji guda ɗaya, ƙarami, kuma na ɗan gajeren lokaci, inda placebo ma ya inganta. Ka ɗauki CoQ10 a matsayin ƙari mai fa’ida da za a tattauna da rheumatologist, ba a matsayin maye gurbin magani mai tabbas ba, har sai an samu ƙarin gwaje‑gwaje manya‑maiya da dogon lokaci.
